Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF)
NO_LONGER_AVAILABLE
Status
Conditions
- Heart Failure With Reduced Ejection Fraction (HF-rEF)
Interventions
Sponsor
Novartis Pharmaceuticals